Mittermayer B. Santiago

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Richard Furie, Brad H. Rovin, Frédéric Houssiau et al. · New England Journal of Medicine · 2020 · 973 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial

Richard Furie, Eric F. Morand, Ian N Bruce et al. · The Lancet Rheumatology · 2019 · 482 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

Richard Furie, Brad H. Rovin, Jay Garg et al. · New England Journal of Medicine · 2025 · 198 citations · Full text

Medicine, Immunology, Pharmacotherapy +15

A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis

Mittermayer B. Santiago, Murray Baron, Kiyomitsu Miyachi et al. · Clinical Rheumatology · 2007 · 100 citations

Life Sciences, Immunology, Internal Medicine +12

Gender characterization in a large series of Brazilian patients with spondyloarthritis

Hellen M.S. Carvalho, Adriana Bruscato Bortoluzzo, Célio Roberto Gonçalves et al. · Clinical Rheumatology · 2011 · 71 citations

Social Sciences, Gender Studies, Gender +11